Roche discontinues low dose in Huntington’s trial

Roche is stopping patients on the low dose of its experimental Huntington’s drug tominersen, and will be transitioning them to the high dose following recommendations by an independent data monitoring committee. The Swiss pharma is ...

Apr 17, 2025 - 16:32
 0
Roche discontinues low dose in Huntington’s trial
Roche is stopping patients on the low dose of its experimental Huntington’s drug tominersen, and will be transitioning them to the high dose following recommendations by an independent data monitoring committee. The Swiss pharma is ...